FDA clears Koios Medical's breast cancer software

By AuntMinnie.com staff writers

July 11, 2019 -- The U.S. Food and Drug Administration (FDA) has cleared artificial intelligence (AI) software developer Koios Medical's machine-learning software for the classification and diagnosis of breast cancer.

Koios DS Breast 2.0 helps clinicians analyze breast ultrasound images and generates a probability of malignancy score with a corresponding BI-RADS category, the company said. It can be used with most PACS platforms and is available on GE Healthcare's Logiq E10, according to Koios.


Copyright © 2019 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: